Leading through complexity: How Trinity Life Sciences CEO Scott Evangelista is redefining strategy in the age of AI

In an industry defined by uncertainty, few leaders have built their careers as deliberately around navigating complexity as Scott Evangelista. As CEO of Trinity Life Sciences, a firm at the intersection of biopharma strategy, data, and commercialization, Evangelista is steering the company through one of the most consequential shifts the industry has seen in decades. This shift is driven by the convergence of artificial intelligence, pricing pressure, and increasingly personalized medicine. The post Leading through complexity: How Trinity Life Sciences CEO Scott Evangelista is redefining strategy in the age of AI appeared first on Digital Journal.